RE: Lth’s30 Jan 2022 19:01
StockBox interview more of the same, nothing new. It does frustrate me when asked for an investment case they harp on about property prices! capital gains on some bricks and mortar is NOT the investment case for ECR and should not be considered as such, if the properties go up a bit in value then great, but save the interview time for discussing gold related assets.
Was hoping for a little more than a rehash of what we already know, as I know they are in contact with ECR from time to time. There was a mention of assay delays, but I don't buy that CresWick results are due to lab delays, can't be, as we've had subsequent core result back from way later.
Some good assays, a strong CEO, some license news and a great PR campaign by Andrew Scott will get this moving. And we all wait with baited breath.